Toronto, Ontario–(February 3, 2021) – Datametrex AI Limited (TSXV: DM) (FSE: D4G) (OTC Pink: DTMXF) (the “Company” or “Datametrex”) is pleased to announce that senior management will be hosting an investor update webinar on Tuesday, February 9, 2021, at 1:30 p.m. EST for a corporate update on the latest developments of the Artificial Intelligence technologies and COVID-19 test kits.
Datametrex plans to answer questions previously sent to [email protected] and during the webinar, at management’s discretion and subject to time constraints.
Posted by AGORACOM
at 1:08 PM on Wednesday, February 3rd, 2021
1st tranche of $4M
Insiders Participating
Expected to Close Further $1M
Loncor Resources Inc. (“Loncor” or the “Company“) (TSX: “LN”; OTCQX: “LONCF”; FSE: “LO51”) is pleased to announce that, further to its January 22, 2021 press release, it has closed a first tranche of its non-brokered private placement financing (the “Financing“) for 8,000,000 units of the Company (the “Units”) at a price of Cdn$0.50 per Unit for gross proceeds of Cdn$4,000,000. Each Unit consists of one common share of the Company and one-half of one common share purchase warrant (each whole common share purchase warrant, a “Warrant“) of the Company, with each Warrant entitling the holder thereof to acquire one common share of the Company at an exercise price of Cdn$0.75 for a period of 12 months following the closing date of the Financing. A total of 1,400,000 of the Units were purchased by insiders of the Company. The Company expects to close the balance of the Financing (up to 2,000,000 Units at a price of Cdn$0.50 per Unit for gross proceeds of up to Cdn$1,000,000) next week.
The Company intends to use the proceeds from the Financing for continued exploration and development of the Company’s Imbo Project (including finalizing the current drill program at the Adumbi gold deposit and, following this program, undertaking a Preliminary Economic Assessment of Adumbi and its neighbouring deposits) and for general corporate purposes.
Posted by AGORACOM
at 12:58 PM on Wednesday, February 3rd, 2021
LAS VEGAS and VANCOUVER, British Columbia, Feb. 03, 2021 — TAAT ™ LIFESTYLE & WELLNESS LTD. (CSE: TAAT) (OTCQB: TOBAF) (FRANKFURT: 2TP2) (the “Company” or “TAAT ™ ”) is pleased to announce that an article profiling the Company was published earlier today by Forbes, marking the first national mainstream media coverage of TAAT™ in the United States. Forbes contributor Amanda Siebert, who primarily covers media stories in the “Vices” category, summarizes her interview with TAAT™ Chief Executive Officer Setti Coscarella, in which Mr. Coscarella shared his professional background and journey to his current role at the Company. Additionally, the article features Mr. Coscarella’s comments on recent events relating to the Company including its engagement with consumer packaged goods (“CPG”) sales agency CROSSMARK, as announced in the Company’s February 2, 2021 press release.
Following a detailed preamble on TAAT™ and Mr. Coscarella, the article goes into detail about the value proposition of TAAT™ as an alternative to tobacco cigarettes due to its inherently non-addictive properties. As differentiation points of TAAT™ among other tobacco-free cigarettes on the market, Mr. Coscarella explains the importance of a tobacco-like taste as well as a competitive price point, which the Company has attained by offering TAAT™ to legal-aged smokers in Ohio for USD $3.99 per pack, compared to approximately USD $7.00 per pack for Marlboro.
Posted by AGORACOM-JC
at 12:12 PM on Wednesday, February 3rd, 2021
Approved for listing on the OTCQB ® Venture Market (“OTCQB ®”), a US trading platform that is operated by the OTC Markets Group in New York.
Effective tomorrow February 4, the Company will commence trading on the OTCQB ® under the symbol KWEMF.
Company establishes U.S. subsidiary and operating facility in Stafford, VA
Ottawa, Ontario–(February 3, 2021) – KWESST Micro Systems Inc. (TSXV: KWE) (“KWESST” or “the Company”) today announced that its common shares have been approved for listing on the OTCQB ® Venture Market (“OTCQB ®”), a US trading platform that is operated by the OTC Markets Group in New York. Effective tomorrow February 4, the Company will commence trading on the OTCQB ® under the symbol KWEMF.
The Company’s common shares will continue to trade on the TSX Venture Exchange under the symbol KWE. Investors can find real-time quote and other information on the Company at https://www.otcmarkets.com/stock/KWEMF/overview. In addition, the Company is pleased to announce that it has received DTC eligibility by The Depository Trust Company (“DTC”) for electronic settlement and transfer of its common shares in the United States.
KWESST Executive Chairman, David Luxton, commented that, “We have a strong concentration of business with military customers in the U.S., so it makes sense to be listed there. As well, there is obviously a much larger potential investor base in the U.S. with an appetite for exposure to our kind of business. We expect this will expand our shareholder base and the liquidity of the stock to the benefit of all shareholders.”
The Company added that in conjunction with its U.S. listing it has established a wholly-owned U.S. subsidiary and operating facility in Stafford, VA where KWESST systems can be assembled and showcased for U.S. customers.
Posted by AGORACOM
at 10:11 AM on Wednesday, February 3rd, 2021
Molecule, Vortex and the OCS worked together to complete the requirements for the deal
Eleven of Molecule’s cannabis-infused beverage products have been submitted for sale on the OCS via Vortex
$MLCL.ca anticipates shipping to the OCS as early as March
February 3 2021, – Ottawa, Ontario – Molecule Holdings Inc. (C NSX :MLCL. CN ) (“ Molecule ” or the “ Company ”), a Canadian craft-focused cannabis beverage production company, is pleased to announce that its sales partner, Vortex Cannabis Inc. (“ Vortex ”) has signed a Master Supply Agreement with the Ontario Cannabis Store ( “OCS” ).
The agreement is in relation to 11 products that were previously submitted by Molecule, and have now been resubmitted with Vortex as licensed sales partner.
“We continue to be incredibly pleased with the development of the partnership with Vortex. Within a week of signing the sales amendment partnership, Molecule, Vortex and the OCS worked together to complete the requirements for the Master Supply Agreement, and have now submitted 11 SKUS to be sold to the OCS through Vortex. This is great news for bringing the craft shelf to market ,” said President and CEO Phil Waddington.
“In anticipation of shipping to the OCS as early as March, we have switched gears from test production runs to inventory-ready production runs of all 11 products,” he added.
Posted by AGORACOM
at 9:57 AM on Wednesday, February 3rd, 2021
Doubles the size of the bought deal to $10 million
Red Light Holland Corp. (“Red Light Holland” or the “Company”) (CSE:TRIP), an Ontario-based corporation positioning itself to engage in the production, growth and sale of a premium brand of magic truffles to the legal, recreational market within the Netherlands, is pleased to announce that it has entered into an amended agreement with Eight Capital, pursuant to which Eight Capital has now agreed to buy, on a bought deal basis, 23,000,000 units (“Units”) at a price of $0.44 per Unit (the “Issue Price”), for gross proceeds of $10,120,000 (the “Offering”).
The Company has agreed to grant Eight Capital an over-allotment option to purchase up to an additional 15% of the Units at the Issue Price, exercisable in whole or in part, at any time on or prior to the date that is 30 days following the closing of the Offering. If this option is exercised in full, an additional approximately $1,500,000 will be raised pursuant to the Offering and the aggregate proceeds of the Offering will be approximately $11,600,000.
Posted by AGORACOM
at 8:41 AM on Wednesday, February 3rd, 2021
Red Light Holland Corp. (“Red Light Holland” or the “Company”) (CSE:TRIP), an Ontario-based corporation positioning itself to engage in the production, growth and sale of a premium brand of magic truffles to the legal, recreational market within the Netherlands, is pleased to announce that it has entered into a letter of engagement with Eight Capital, under which Eight Capital has agreed to purchase, as sole bookrunner and underwriter, 11,600,000 units of the Company (the “Units”), on a “bought deal” basis pursuant to a filing of a short form prospectus, subject to all required regulatory approvals, at a price per Unit of $0.44 (the “Issue Price”) for gross proceeds of $5,060,000 (the “Offering”).
The Company has agreed to grant Eight Capital an over-allotment option to purchase up to an additional 15% of the Units at the Issue Price, exercisable in whole or in part, at any time on or prior to the date that is 30 days following the closing of the Offering. If this option is exercised in full, an additional approximately $750,000 will be raised pursuant to the Offering and the aggregate proceeds of the Offering will be approximately $5,750,000.
Each Unit will be comprised of one common share of the Company (a “Common Share”) and one Common Share purchase warrant (a “Warrant”). Each Warrant shall entitle the holder thereof to purchase one Common Share at an exercise price of $0.70, for a period of 36 months following the closing of the Offering. If the daily volume weighted average trading price of the Common Shares on the Canadian Securities Exchange for any 10 consecutive days equals or exceeds $1.52, the Company may, upon providing written notice to the holders of the Warrants, accelerate the expiry date of the Warrants to the date that is 30 days following the date of such written notice.
Posted by AGORACOM-JC
at 8:40 AM on Wednesday, February 3rd, 2021
Appointed Mr. José Abbo, former chairman of Panama’s $1.5 billion Sovereign Wealth Fund, as chairman of the PlantX Advisory Team
The Advisory Team is composed of respected executives in the business, marketing and finance industries and will play a key role in guiding the Company’s growth-oriented business strategy.
VANCOUVER, BC , Feb. 3, 2021 – PlantX Life Inc. (the ” Company ” or ” PlantX “) (CSE: VEGA ) (Frankfurt: WNT1) (OTCQB: PLTXF) is pleased to announce that it has appointed Mr. José Abbo, former chairman of Panama’s $1.5 billion Sovereign Wealth Fund, as chairman of the PlantX Advisory Team (the ” Advisory Team “). The Advisory Team is composed of respected executives in the business, marketing and finance industries and will play a key role in guiding the Company’s growth-oriented business strategy.
With more than 30 years of financial experience, Mr. Abbo is a prominent leader, writer and visionary in the capital markets sector. Mr. Abbo’s commitment to excellence has consistently been proven throughout his many roles, including as a financial strategist, financial advisor and investment consultant.
Mr. Abbo’s expertise will bring business development and leadership skills to assist with fostering innovation and collaboration across the Company.
“We are thrilled and honoured to have Mr. Abbo join PlantX,” said Sean Dollinger , PlantX founder. “His appointment as the Chairman of our Advisory Team is a testament to PlantX’s commitment to attracting exceptional professionals who are dedicated to our mission to improve lives and grow are leaders in the plant-based industry.”
PlantX Advisory Team
In addition to Mr. Abbo, the Advisory Team consists of the following members:
Ralph Moxness – President of Greenfields Investment Corporation, a firm he founded in 1987 that specializes in advisory services related to mergers & acquisitions and corporate finance. He has extensive experience in banking and finance.
Michael Galloro – an accomplished financial executive with over 25 years of experience. He works closely with emerging private and publicly listed companies.
Bernie Tevel – brings a background in sales and marketing to the PlantX team. He has worked in fashion and manufacturing throughout most of his professional life.
Joel Milgram – Former CFO and Proprietor of Milgram & Company until the company was acquired by C.H. Robinson in 2017. C.H Robinson was ranked as one of Canada’s 50 best managed companies by the National Post, Deloitte and CIBC. He has served on finance committees for various schools and charities, is currently a canvasser for Federation CJA, and focuses on mentoring in the fashion industry.
Johnny Karls – brings many years of experience in worldwide distribution.
John Di Girolamo – an experienced investor and entrepreneur with 20 years of global business experience in both the public and private sectors.
Fred Leigh – has played a key founding and executive role in the junior resources sector for nearly four decades and has founded and invested in many public companies. He plays a critical role at Forbes & Manhattan , a private merchant bank, in assisting CEOs and CFOs in funding, market support, and business advice.
About PlantX Life Inc.
As the digital face of the plant-based community, PlantX’s platform is the one-stop-shop for everything plant-based. With its fast-growing category verticals, the Company offers customers across North America more than 10,000 plant-based products. In addition to offering meal and indoor plant deliveries, the Company currently has plans underway to expand its product lines to include cosmetics, clothing, and its own water brand — but the business is not limited to an e-commerce platform. The Company uses its digital platform to build a community of like-minded consumers, and most importantly, provide education. Its successful enterprise is being built and fortified on partnerships with top nutritionists, chefs and brands. The Company eliminates the barriers to entry for anyone interested in living a plant-based lifestyle and thriving in a longer, healthier and happier life.
About José Abbo
José Abbo has more than 30 years of experience in the financial sector as a senior executive, having developed numerous benchmark studies, financial performance analyses, competitive intelligence analyses and economic analyses and research. In 2012, he was appointed member of the Board of Directors of the Panama Savings Fund (State Sovereign Fund), for a period of seven years, a position which has just been ratified for a second term. Mr. Abbo is a prominent speaker who is consistently invited to international events and is a published author in The Economist and the Wall Street Journal . In 2000, Mr. Abbo achieved international prestige upon publishing a book titled ‘Divisando Wall Street’ on analyzing securities markets and companies. In 2008, he published another book called ‘The Big Gamble: Are You Investing or Speculating,” co-written with José D. Ronca.
Posted by AGORACOM-JC
at 8:29 AM on Wednesday, February 3rd, 2021
Entered into a channel partnership agreement with SensorSuite Inc. to deliver SensorSuite’s Artificial Intelligence Energy Cloud Ecosystem Platform to multi-unit residential building and non-BAS customers across Canada
SensorSuite’s E.C.E platform seamlessly monitors, controls and optimizes Electricity, Gas and Water assets.
Using AI algorithms, the Energy Cloud Ecosystem aggregates and co-ordinates Distributed Energy Resources to eliminate wastage and increase operational efficiency.
Toronto, Ontario–(February 3, 2021) – Universal PropTech Inc. (TSXV: UPI) (“UPI” or the “Company“) is pleased to announce that it has entered into a channel partnership agreement (“Agreement“) with SensorSuite Inc. (“SensorSuite“) to deliver SensorSuite’s Artificial Intelligence (“AI“) Energy Cloud Ecosystem (“E.C.E“) Platform to multi-unit residential building (“MURB”) and non-BAS customers across Canada.
“Universal PropTech is pleased to bring SensorSuite’s AI platform to our MURB customers and prospects,” stated Chris Hazelton, President and CEO of UPI. “The inclusion of Artificial Intelligence is another tool in our expanding Building Performance offering to improve our evidence-based approach, ongoing services revenues and sustain our Trusted Advisor status.”
SensorSuite’s E.C.E platform seamlessly monitors, controls and optimizes Electricity, Gas and Water assets. Using AI algorithms, the Energy Cloud Ecosystem aggregates and co-ordinates Distributed Energy Resources to eliminate wastage and increase operational efficiency.
SensorSuite has deployed their AI solution in over 157 MURBs in Canada generating 12 billion data points per year. The Energy Cloud Ecosystem can generate between 20% to 30% in energy efficiency for MURB owners and managers, in an ongoing service model.
VCI Controls, a UPI wholly owned subsidiary, has provided services to over 2000 buildings in over 40 years, and will assess opportunities to generate Building Performance revenues with past, current customers and new prospects.
Glen Spry, President and CEO of SensorSuite, “We are excited to have Universal PropTech actively drive sales in Canada. Having a 40-year controls company like VCI Controls, enables us to start to scale the success of our AI Energy Cloud Ecosystem Platform.”
Posted by AGORACOM
at 8:29 AM on Wednesday, February 3rd, 2021
Announces Psychedelic Pharmaceutical Production Agreement
Synthesis of pharmaceutical grade psychedelic compounds
Working toward regulatory approval for the commercial production process
XPhyto Therapeutics Corp. (CSE:XPHY)(OTCQB:XPHYF)(FSE:4XT) (“XPhyto” or the “Company”) is pleased to announce that XPhyto Laboratories Inc. (“XPhyto Labs”), its wholly owned Alberta subsidiary, has signed an agreement (the “Agreement”) with Applied Pharmaceutical Innovation (“Applied”) for the synthesis of pharmaceutical grade psychedelic compounds and the parallel development of the standard operating procedures necessary to obtain regulatory approval for the respective commercial production process.
The industrial-scale production of standardized active pharmaceutical ingredients is an important part of XPhyto’s psychedelic pharmaceutical program as the Company anticipates a shortage of large-scale supply of certain approved and standardized pharmaceutical grade psychedelics.
Applied is a not-for-profit institution at the University of Alberta created to support translational drug development for industry and innovators. With an interdisciplinary team of over 30 pharmaceutical scientists, clinicians, regulatory, patent, and market experts, Applied provides industry with access to translational science in a framework that supports commercial success. This includes retention of IP and ownership of work product for the funder, focused and efficient project execution, and regulatory compliant operations.
